USPTO serial 99537817
AIPING PHARMACEUTICAL, INC.
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- TANNER, MICHAEL R
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with AIPING PHARMACEUTICAL, INC.?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
NANCY A. DEL PIZZO
NANCY A. DEL PIZZO RIVKIN RADLER LLP25 Main StreetCourt Plaza North, Suite 501Hackensack, NJ 07601Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of pain and inflammation, hypertension, diabetes, cardiac arrhythmias, hyperphosphatemia, hyperlipidemia, bacterial infections, gastrointestinal disorders, respiratory disorders, psychiatric disorders, neurologic disorders, and urologic disorders | ACTIVE | — |
| 035 | Online wholesale store services for licensed sellers of pharmaceuticals, featuring prescription pharmaceuticals sold only for use by licensed purchasers of such pharmaceuticals; procurement, namely, purchasing prescription pharmaceuticals for others | ACTIVE | — |
| 042 | Pharmaceutical research and development for others; laboratory testing and quality control for pharmaceuticals, namely, laboratory testing services for the production of pharmaceuticals in the nature of testing of pharmaceuticals for others, Inspection of pharmaceuticals for quality control purposes for others; analytical method development and validation, namely, development and establishment of testing specifications and procedures for others in the pharmaceutical industry; formulation development, namely, scientific research and development of pharmaceutical formulations for others; stability testing, namely, testing, analysis, and evaluation of pharmaceuticals for others to assure compliance with industry standards, testing of pharmaceuticals for shelf life stability for others; conducting clinical trials for others | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Aiping Pharmaceutical, Inc.
- Other trademarks owned by Aiping Pharmaceutical, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named AIPING PHARMACEUTICAL, INC.
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 11, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 16, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 16, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 10, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 19, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 21, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 21, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 21, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 21, 2026 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Apr 21, 2026 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Apr 21, 2026 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Apr 21, 2026 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Apr 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 6, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 9, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 9, 2025 | NWAP | NEW APPLICATION ENTERED | — |